Why the study?
Hypertension is prevalent and modifiable in dialysis patients, contributing to heightened cardiovascular risk, while intradialytic hypotension frequently causes symptoms, myocardial injury, and increased mortality.
This document summarizes the UK clinical practice guideline for managing blood pressure in patients undergoing dialysis.
Supports individualized BP targets and IDH prevention strategies in dialysis; extends evidence into actionable recommendations for CV risk reduction.
Hypertension is one of the most prevalent and modifiable risk factors for cardiovascular disease and mortality in patients undergoing dialysis.1-3 Affecting approximately 90% of individuals with end-stage kidney disease on dialysis, elevated blood pressure (BP) significantly contributes to the already heightened cardiovascular risk in this population.4 Conversely, intradialytic hypotension (IDH)—a frequent complication during hemodialysis—can lead to debilitating symptoms, myocardial injury, and increased mortality.
No takes yet. Share an insight, caveat, or question.
Dasgupta et al. (2026) conducted a review in Hypertension in end-stage kidney disease on dialysis. Blood pressure management was evaluated. Elevated blood pressure affects approximately 90% of individuals with end-stage kidney disease on dialysis, significantly contributing to heightened cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: